search icon
slxn-img

Biomotion Sciences Ordinary Shares, Common Stock

SLXN

NMQ

$1.94

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.11M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
68.35K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.21 L
$13.56 H
$1.94

About Biomotion Sciences Ordinary Shares, Common Stock

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSLXNSectorS&P500
1-Week Return-9.77%0.49%-0.42%
1-Month Return-28.68%-3.1%-2.2%
3-Month Return519.41%-8.59%2.38%
6-Month Return-84.1%-4.57%5.1%
1-Year Return-82.4%-0.94%23.79%
3-Year Return-80%2.88%26.66%
5-Year Return-80.6%35.84%81.16%

Financials

Dec '12Dec '22Dec '23
Total Revenue---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses-3.86M4.68M[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":82.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income-(3.86M)(4.68M)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-386000000,"profit":false},{"date":"2023-12-31","value":-468100000,"profit":false}]
Total Non-Operating Income/Expense-396.00K(395.00K)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.75,"profit":false}]
Pre-Tax Income-(3.46M)(5.08M)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-346400000,"profit":false},{"date":"2023-12-31","value":-507600000,"profit":false}]
Income Taxes---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(3.49M)(5.11M)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-348800000,"profit":false},{"date":"2023-12-31","value":-510800000,"profit":false}]
Income From Discontinued Operations---[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income-(3.21M)(4.94M)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-321500000,"profit":false},{"date":"2023-12-31","value":-494200000,"profit":false}]
EPS (Diluted)-0.35(0.03)[{"date":"2012-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-7.71,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SLXN
Current Ratio 0.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SLXN
ROA (LTM) -62.13%
ROE (LTM) -116.66%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SLXN
Debt Ratio Lower is generally better. Negative is bad. 2.48
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.48

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SLXN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Biomotion Sciences Ordinary Shares share price today?

Biomotion Sciences Ordinary Shares (SLXN) share price today is $1.94

Can Indians buy Biomotion Sciences Ordinary Shares shares?

Yes, Indians can buy shares of Biomotion Sciences Ordinary Shares (SLXN) on Vested. To buy Biomotion Sciences Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SLXN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biomotion Sciences Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Biomotion Sciences Ordinary Shares (SLXN) via the Vested app. You can start investing in Biomotion Sciences Ordinary Shares (SLXN) with a minimum investment of $1.

How to invest in Biomotion Sciences Ordinary Shares shares from India?

You can invest in shares of Biomotion Sciences Ordinary Shares (SLXN) via Vested in three simple steps:

  • Click on Sign Up or Invest in SLXN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biomotion Sciences Ordinary Shares shares
What is Biomotion Sciences Ordinary Shares 52-week high and low stock price?

The 52-week high price of Biomotion Sciences Ordinary Shares (SLXN) is $13.56. The 52-week low price of Biomotion Sciences Ordinary Shares (SLXN) is $0.21.

What is Biomotion Sciences Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biomotion Sciences Ordinary Shares (SLXN) is

What is Biomotion Sciences Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biomotion Sciences Ordinary Shares (SLXN) is 0.00

What is Biomotion Sciences Ordinary Shares dividend yield?

The dividend yield of Biomotion Sciences Ordinary Shares (SLXN) is 0.00%

What is the Market Cap of Biomotion Sciences Ordinary Shares?

The market capitalization of Biomotion Sciences Ordinary Shares (SLXN) is $3.11M

What is Biomotion Sciences Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Biomotion Sciences Ordinary Shares is SLXN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top